Dr. Matthew Lederman will lead a discussion on how BRCA carriers and patients with Lynch Syndrome and other hereditary cancers can plan and build the families of their dreams. The discussion will cover RMA of New York’s newly published research and cutting edge reproductive medicine technologies helping patients preserve fertility prior to undergoing cancer risk-reducing surgeries. The talk will also cover how IVF with Preimplantation Genetic Diagnosis (PGD) is utilized to prevent the transmission of cancer predisposition syndromes to offspring. There will also be a Q&A for attendees to ask individual questions.
Dr. Matthew Lederman, a board certified Reproductive Endocrinologist and Infertility Specialist at Reproductive Medicine Associates of New York, has extensive clinical experience in all areas of fertility, including egg freezing, PGD, PGS, and fertility preservation for patients recently diagnosed with cancer, and those predisposed to hereditary cancer syndromes. Dr. Lederman is known for his compassionate care and devotion to patients, and is consistently recognized by New York Times Magazine’s “SuperDoctors.” Dr. Lederman serves on the Medical Advisory Board of FORCE: Facing our Risk of Cancer Empowered.
This program was organized in partnership with FORCE, Sema4, SHARE, Sharsheret, and AliveAndKickn.
Understanding Endometriosis Endometriosis is a condition that affects the female reproductive system and occurs when endometrial tissue that is typically only found inside of the uterus begins to develop outside of the uterus. Endometriosis affects roughly 1 out of 10 women in ...READ MORE
Reproductive Medicine Associates of New York and FORCE (Facing Our Risk of Cancer Empowered) Wednesday, May 9, 2018 6 p.m. ...READ MORE
to receive all the latest News, Events & MORE!